ANIKA THERAPEUTICS, INC. Form of Change in Control, Bonus and Severance AgreementAgreement • November 19th, 2004 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledNovember 19th, 2004 Company Industry JurisdictionAGREEMENT made as of October 6, 2004 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Carol A. Toth, of East Walpole, Massachusetts (the “Executive”), an individual presently employed as the Senior Vice President Marketing and Business Development of the Company.
ANIKA THERAPEUTICS, INC. Form of Change in Control, Bonus and Severance AgreementAgreement • August 14th, 2003 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 14th, 2003 Company Industry JurisdictionAGREEMENT made as of June 9, 2003 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Francesco (Frank) J. Luppino, of Melrose, MA (the “Executive”), an individual presently employed as the Vice President Operations of the Company.
Form of Change in Control, Bonus and Severance AgreementAgreement • May 15th, 2003 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMay 15th, 2003 Company Industry JurisdictionAGREEMENT made as of March 17, 2003 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Roger C. Stikeleather, of Doylestown, Pennsylvania (the “Executive”), an individual presently employed as the Vice President Sales and Marketing of the Company.
ANIKA THERAPEUTICS, INC. Change in Control, Bonus and Severance AgreementAgreement • August 14th, 2002 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 14th, 2002 Company Industry JurisdictionAGREEMENT made as of July 8, 2002 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and William J. Knight of Boxford, Massachusetts (the “Executive”), an individual presently employed as the Chief Financial Officer, Vice President of Finance, Treasurer and Clerk of the Company.